{"id":"W2165837347","doi":"10.1016/s0140-6736(09)60500-6","title":"Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial","year":2009,"lang":"en","type":"article","venue":"The Lancet","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":1363,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Medicine; Imatinib mesylate; Imatinib; Placebo; Clinical endpoint; Interim analysis; Internal medicine; GiST; Gastroenterology; Surgery; Oncology; Clinical trial; Stromal cell; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}